Has Harvey Nurick, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,760 in general payments to Harvey Nurick, MD across 34 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Harvey Nurick, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Harvey Nurick, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Harvey Nurick, MD

Surgery · Riverside, CANPI 1720041486

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Integra Lifesciences Corporation at 31.6% of the total. That places this record below the midpoint for surgery clinicians in CA, where the typical reported total is $1,806.

$1,760in general payments, 2019–2025

Across 34 payments — averaging $51.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Integra Lifesciences Corporation$556
Silk Road Medical, Inc.$191
Cardiovascular Systems Inc.$152
Angiodynamics, Inc.$147
Elucent Medical$138
Aroa Biosurgery Incorporated$119
plus $457 from 13 others

$241,394in research payments, 2019–2025

Across 19 payments — averaging $12,705 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Heron Therapeutics, Inc.$214K
Takeda Pharmaceuticals U.S.A., Inc.$27K

What the payments were for

Food & beverage$1,74399%
Education$171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Integra Lifesciences Corporation	7	$556
Silk Road Medical, Inc.	2	$191
Cardiovascular Systems Inc.	2	$152
Angiodynamics, Inc.	1	$147
Elucent Medical	2	$138
Aroa Biosurgery Incorporated	3	$119
Lemaitre Vascular, Inc.	1	$85
Smith+Nephew	2	$71
Medtronic	2	$52
Bard Peripheral Vascular, Inc.	2	$41
TELA Bio, Inc.	1	$37
Trevena, Inc.	2	$33
Imperative Care, Inc	1	$25
AbbVie	1	$23
Tactile Systems Technology Inc	1	$22
Cook Medical LLC	1	$21
Baxter Healthcare	1	$18
Galvanize Therapeutics, Inc	1	$15
Covidien LP	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTEGRA$485
ENROUTE Transcarotid Stent$176
ENROUTE Transcarotid Neuroprotection System$176
INTEGRA DERMAL REGENERATION TEMPLATE$162
PRIMATRIX$162
Auryon Laser System 100-120 Vac$147
SURGIMEND$136

How this compares

$1,760 in reported general payments places this provider in the 45th percentile of 2,363 surgery providers in California.

See all surgery providers in California →

Medicare billing

Part B allowed, 2024

$51,549

Medicare patients

Services billed

201

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	47	$287
ClopidogrelClopidogrel Bisulfate	21	$147
Tramadol Hcl	35	$76
Cephalexin	17	$70

Paid to pharmacies, not to this prescriber.

Other surgery in Riverside

Timothy ChuterSan Francisco$8.8M
Santiago HorganSan Diego$2.8M
Rock LiuHayward$1.6M
David LouriePasadena$1.4M
Andrea PakulaThousand Oaks$1.4M
Siew-Ming LeeFresno$1.3M
Beemen KhalilPalo Alto$1.1M
John LiphamLos Angeles$942K
Alexander NedopilLodi$682K
Barry GardinerSan Ramon$602K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →